In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species
- PMID: 9796657
- DOI: 10.1007/BF01708622
In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species
Abstract
Twenty-nine Aspergillus isolates and 25 Fusarium isolates underwent in vitro antifungal susceptibility testing by a broth macrodilution procedure adapted from the National Committee for Clinical Laboratory Standards guidelines. The MIC50s of both voriconazole and amphotericin B were 0.5 microg/ml and 1 microg/ml against species of Aspergillus and Fusarium, respectively, while the MIC90s of both agents were 1 and 2 microg/ml. Voriconazole was more active in vitro than amphotericin B: the geometric mean MICs of voriconazole and amphotericin B against Aspergillus spp. were 0.36 microg/ml and 0.64 microg/ml, respectively. Voriconazole also demonstrated fungicidal activity against Aspergillus spp., with 86% (24/29) of isolates exhibiting minimum lethal concentrations of < or = 4 microg/ml.
Similar articles
-
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.Antimicrob Agents Chemother. 2002 Apr;46(4):1032-7. doi: 10.1128/AAC.46.4.1032-1037.2002. Antimicrob Agents Chemother. 2002. PMID: 11897586 Free PMC article.
-
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.J Clin Microbiol. 2001 Mar;39(3):954-8. doi: 10.1128/JCM.39.3.954-958.2001. J Clin Microbiol. 2001. PMID: 11230410 Free PMC article.
-
Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.J Clin Microbiol. 1999 Dec;37(12):3946-51. doi: 10.1128/JCM.37.12.3946-3951.1999. J Clin Microbiol. 1999. PMID: 10565912 Free PMC article.
-
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.Mycopathologia. 2001;150(3):101-15. doi: 10.1023/a:1010954803886. Mycopathologia. 2001. PMID: 11469757 Review.
-
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.Rev Iberoam Micol. 2003 Dec;20(4):121-36. Rev Iberoam Micol. 2003. PMID: 15456349 Review.
Cited by
-
Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serum.Antimicrob Agents Chemother. 2013 Apr;57(4):1625-31. doi: 10.1128/AAC.01573-12. Epub 2013 Jan 14. Antimicrob Agents Chemother. 2013. PMID: 23318807 Free PMC article.
-
Application of a Physiologically Based Pharmacokinetic Model to Characterize Time-dependent Metabolism of Voriconazole in Children and Support Dose Optimization.Front Pharmacol. 2021 Mar 17;12:636097. doi: 10.3389/fphar.2021.636097. eCollection 2021. Front Pharmacol. 2021. PMID: 33815119 Free PMC article.
-
Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology.Antimicrob Agents Chemother. 2007 Sep;51(9):3329-37. doi: 10.1128/AAC.00345-07. Epub 2007 Jun 18. Antimicrob Agents Chemother. 2007. PMID: 17576838 Free PMC article.
-
Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.Antimicrob Agents Chemother. 2000 Oct;44(10):2865-8. doi: 10.1128/AAC.44.10.2865-2868.2000. Antimicrob Agents Chemother. 2000. PMID: 10991875 Free PMC article.
-
Pharmacokinetic study of voriconazole administered orally at 50 mg/kg in nursehound sharks (Scyliorhinus stellaris) and udulate skates (Raja undulata).BMC Vet Res. 2025 Jul 23;21(1):484. doi: 10.1186/s12917-025-04930-6. BMC Vet Res. 2025. PMID: 40702510 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous